Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Rheumatology (Oxford, England)
|
March 7, 2014
What drives the comparative effectiveness of biologics vs. methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors
Steve Kanters, Eric Druyts, Edward J Mills, et al.
Expert Review of Gastroenterology & Hepatology
|
March 13, 2015
Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs
Kristian Thorlund, Eric Druyts, Kabirraaj Toor, et al.
Clinical Epidemiology
|
March 27, 2020
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review
Kevin Yan, Kamal Desai, Lakshmi Gullapalli, et al.
Clinical Epidemiology
|
April 14, 2011
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
Edward J Mills, Eric Druyts, Isabella Ghement, et al.
Current Medical Research and Opinion
|
February 8, 2024
Humanistic burden of mucopolysaccharidoses: a systematic literature review
Joyce Wai-Yin Li, Kevin Yan, Chakrapani Balijepalli, et al.
Journal of Comparative Effectiveness Research
|
February 5, 2021
Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes
Chakrapani Balijepalli, Kevin Yan, Michael Zoratti, et al.
Multiple Sclerosis and Related Disorders
|
June 17, 2020
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis
Kevin Yan, Chakrapani Balijepalli, Kamal Desai, et al.
Journal of Comparative Effectiveness Research
|
November 29, 2019
Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma
Rohini Sharma, Roy Koruth, Steve Kanters, et al.
Cost Effectiveness and Resource Allocation : C/E
|
March 15, 2014
The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
Kristian Thorlund, Zafar Zafari, Eric Druyts, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
November 28, 2012
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
Kristian Thorlund, Eric Druyts, Antoine C El Khoury, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Rheumatology (Oxford, England)
|
March 7, 2014
What drives the comparative effectiveness of biologics vs. methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors
Steve Kanters, Eric Druyts, Edward J Mills, et al.
Expert Review of Gastroenterology & Hepatology
|
March 13, 2015
Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs
Kristian Thorlund, Eric Druyts, Kabirraaj Toor, et al.
Clinical Epidemiology
|
March 27, 2020
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review
Kevin Yan, Kamal Desai, Lakshmi Gullapalli, et al.
Clinical Epidemiology
|
April 14, 2011
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
Edward J Mills, Eric Druyts, Isabella Ghement, et al.
Current Medical Research and Opinion
|
February 8, 2024
Humanistic burden of mucopolysaccharidoses: a systematic literature review
Joyce Wai-Yin Li, Kevin Yan, Chakrapani Balijepalli, et al.
Journal of Comparative Effectiveness Research
|
February 5, 2021
Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes
Chakrapani Balijepalli, Kevin Yan, Michael Zoratti, et al.
Multiple Sclerosis and Related Disorders
|
June 17, 2020
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis
Kevin Yan, Chakrapani Balijepalli, Kamal Desai, et al.
Journal of Comparative Effectiveness Research
|
November 29, 2019
Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma
Rohini Sharma, Roy Koruth, Steve Kanters, et al.
Cost Effectiveness and Resource Allocation : C/E
|
March 15, 2014
The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD
Kristian Thorlund, Zafar Zafari, Eric Druyts, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
November 28, 2012
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
Kristian Thorlund, Eric Druyts, Antoine C El Khoury, et al.
Page
of 7